HIGHLIGHTS
- who: Min Dai from the Department of, Yunnan University Affiliated Hospital, Yunnan, China have published the research work: Based on multiple machine learning to identify the ENO2 as diagnosis biomarkers of glaucoma, in the Journal: (JOURNAL)
- what: The research shows that ENO2 NAMPT and ADH1C can be used as diagnostic markers for glaucoma and ENO2 can be used as a therapeutic target. The authors used the limma package of R to compare the differences of gene_expression levels between glaucoma / normal sample groups.
- how: This study obtains glaucoma clinical data from the public database . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.